Lynn L. Silver

14.0k total citations · 2 hit papers
73 papers, 5.4k citations indexed

About

Lynn L. Silver is a scholar working on Molecular Biology, Molecular Medicine and Genetics. According to data from OpenAlex, Lynn L. Silver has authored 73 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 22 papers in Molecular Medicine and 18 papers in Genetics. Recurrent topics in Lynn L. Silver's work include Antibiotic Resistance in Bacteria (22 papers), Bacterial Genetics and Biotechnology (16 papers) and Microbial Natural Products and Biosynthesis (12 papers). Lynn L. Silver is often cited by papers focused on Antibiotic Resistance in Bacteria (22 papers), Bacterial Genetics and Biotechnology (16 papers) and Microbial Natural Products and Biosynthesis (12 papers). Lynn L. Silver collaborates with scholars based in United States, Switzerland and Israel. Lynn L. Silver's co-authors include Katherine Young, Keith A. Bostian, Nancy G. Nossal, Sheo B. Singh, Malabi M. Venkatesan, Joyce Kohler, Matt S. Anderson, Sheryl A. Hyland, Christian R.H. Raetz and Michaël Chandler and has published in prestigious journals such as Nature, Science and Journal of the American Chemical Society.

In The Last Decade

Lynn L. Silver

70 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Challenges of Antibacterial Discovery

2011 987 citations Lynn L. Silver profile →
Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is needed.

2022 167 citations Mark S. Butler, Valeria Gigante et al. Oxford University Research Archive (ORA) (University of Oxford) profile →

Peers

Countries citing papers authored by Lynn L. Silver

Since Specialization

Citations

This map shows the geographic impact of Lynn L. Silver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynn L. Silver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynn L. Silver more than expected).

Fields of papers citing papers by Lynn L. Silver

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynn L. Silver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynn L. Silver. The network helps show where Lynn L. Silver may publish in the future.

Co-authorship network of co-authors of Lynn L. Silver

This figure shows the co-authorship network connecting the top 25 collaborators of Lynn L. Silver. A scholar is included among the top collaborators of Lynn L. Silver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynn L. Silver. Lynn L. Silver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lasso-shaped molecule is a new type of broad-spectrum antibiotic 2025 ·Nature ·Lynn L. Silver	2
2	Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is needed. breakdown → 2022 ·Oxford University Research Archive (ORA) (University of Oxford) ·Mark S. Butler, Valeria Gigante, Hatim Sati, Sarah Paulin, (unknown), John Rex, Prabhavathi Fernandes, César A. Arias, Mical Paul, Guy Thwaites, Lloyd G. Czaplewski, Richard A. Alm, Christian Lienhardt, Melvin Spigelman, Lynn L. Silver, Norio Ohmagari, Roman S. Kozlov, Stephan Harbarth, Peter Beyer	167
3	Analysis of the clinical antibacterial and antituberculosis pipeline 2018 ·The Lancet Infectious Diseases ·Ursula Theuretzbacher, (unknown), Peter Beyer, Mark S. Butler, Lloyd G. Czaplewski, Christian Lienhardt, Lorenzo Moja, Mical Paul, Sarah Paulin, John Rex, Lynn L. Silver, Melvin Spigelman, Guy Thwaites, Jean‐Pierre Paccaud, Stéphan Harbarth	159
4	Fosfomycin: Mechanism and Resistance 2017 ·Cold Spring Harbor Perspectives in Medicine ·Lynn L. Silver	221
5	What is an “ideal” antibiotic? Discovery challenges and path forward 2017 ·Biochemical Pharmacology ·Sheo B. Singh, Katherine Young, Lynn L. Silver	156
6	A Gestalt approach to Gram-negative entry 2016 ·Bioorganic & Medicinal Chemistry ·Lynn L. Silver	135
7	Appropriate Targets for Antibacterial Drugs 2016 ·Cold Spring Harbor Perspectives in Medicine ·Lynn L. Silver	50
8	Antibacterials for any target 2014 ·Nature Biotechnology ·Lynn L. Silver	5
9	Viable screening targets related to the bacterial cell wall 2012 ·Annals of the New York Academy of Sciences ·Lynn L. Silver	47
10	Are natural products still the best source for antibacterial discovery? The bacterial entry factor 2008 ·Expert Opinion on Drug Discovery ·Lynn L. Silver	57
11	Does the cell wall of bacteria remain a viable source of targets for novel antibiotics? 2005 ·Biochemical Pharmacology ·Lynn L. Silver	91
12	Determination of Selectivity and Efficacy of Fatty Acid Synthesis Inhibitors 2004 ·Journal of Biological Chemistry ·Srinivas Kodali, Andrew Galgoci, Katherine Young, Ronald E. Painter, Lynn L. Silver, Kithsiri Herath, Sheo B. Singh, Doris Cully, John F. Barrett, Dennis M. Schmatz, Jun Wang	93
13	Direct interaction of a vancomycin derivative with bacterial enzymes involved in cell wall biosynthesis 2001 ·Chemistry & Biology ·Ranabir Sinha Roy, Chaoho Ouyang, Srinivas Kodali, Yusheng Xiong, Ronald M. Kim, Patrick R. Griffin, Hiroshi Ōnishi, Joyce Kohler, Lynn L. Silver, Kevin T. Chapman	36
14	Ocular Comfort of Brinzolamide 1.0% Ophthalmic Suspension Compared With Dorzolamide 2.0% Ophthalmic Solution 2000 ·Survey of Ophthalmology ·Lynn L. Silver, (unknown)	78
15	Dose-Response Evaluation of the Ocular Hypotensive Effect of Brinzolamide Ophthalmic Suspension (Azopt®) 2000 ·Survey of Ophthalmology ·Lynn L. Silver, (unknown)	47
16	Inhibition of IMP-1 metallo-Î²-lactamase and sensitization of IMP-1-producing bacteria by thioester derivatives 1999 ·FEMS Microbiology Letters ·Gail G. Hammond, Joann Huber, Mark L. Greenlee, (unknown), Katherine Young, Lynn L. Silver, James M. Balkovec, KellyAnn D. Pryor, Joseph K. Wu, Barbara Leiting, David L. Pompliano, Jeffrey H. Toney	42
17	The envA Permeability/Cell Division Gene of Escherichia coli Encodes the Second Enzyme of Lipid A Biosynthesis 1995 ·Journal of Biological Chemistry ·Katherine Young, Lynn L. Silver, David Bramhill, Patricia M. Cameron, Suzanne S. Eveland, Christian R.H. Raetz, Sheryl A. Hyland, Matt S. Anderson	157
18	Models of B-cell Unresponsiveness 1989 ·Cold Spring Harbor Symposia on Quantitative Biology ·David W. Scott, (unknown), J H Chace, (unknown), Lynn L. Silver, Garvin L. Warner	6
19	Suppression of an Escherichia coli dnaA mutation by the integrated R factor R100.1: origin of chromosome replication during exponential growth 1977 ·Journal of Bacteriology ·Michaël Chandler, Lynn L. Silver, L. Caro	38
20	Noncommutative localizations and applications 1967 ·Journal of Algebra ·Lynn L. Silver	114

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact